PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Aging hepatitis C population escalates demand for liver transplantation

Increase driven by liver cancer development in baby boomers

2012-12-06
(Press-News.org) New research reveals that the greatest demand for liver transplantation due to hepatitis C (HCV)-related liver disease occurs among Americans born between 1941 and 1960. Findings in the December issue of Liver Transplantation, a journal published by Wiley on behalf of the American Association for the Study of Liver Diseases (AASLD), suggest that continuing increased demand for transplantation is driven by the development of liver cancer in baby boomers with HCV, but that the demand may decrease as patients born in this time period continue to grow older.

HCV is the most common blood-borne infection and cause of liver disease requiring transplantation in the U.S., chronically infecting more than one percent of Americans. Previous studies show that among patients living with chronic HCV, 10% to 20% will develop cirrhosis and up to 5% will progress to liver cancer (hepatocellular carcinoma; HCC). Further evidence implicates HCV as the primary risk factor for developing HCC in up to 47% of cases of patients with HCC.

The peak U.S. HCV prevalence of 4% occurred in those born in 1940 through 1965, who were 20 to 30 years of age during 1979 to 1989, when HCV infection risk was at its highest. As this population ages, Davis et al. project that between 2000 and 2030 cirrhosis in patients with HCV will increase two-fold, from 472,000 to 879,000. Moreover, Wise et al. suggests HCV-related deaths will increase in Americans 55 to 64 years of age by 2004.

"The dire projections in HCV complications spurred our investigation of age-specific trends in liver transplantation demand," said lead author Dr. Scott Biggins with the University of Colorado School of Medicine in Aurora, Colo. For the present study, researchers identified all adult liver transplant candidates who were registered with the Organ Procurement and Transplantation Network (OPTN) between 1995 and 2010. Patients were then classified with the diagnosis of HCV, with or without HCC.

Results show there were 126,862 new candidates for first liver transplant registered with OPTN, with 41% of these having HCV. Candidates were categorized by birth year and found that the highest HCV frequency (in decreasing order) were those born in 1951-1955, 1956-1960, 1946-1950, and 1941-1945. These four birth groups represent 81% of all new liver transplant registrants with HCV.

Furthermore, findings indicate that between 2000 and 2010 there was a four-fold increase in new transplant candidates with HCV and HCC in the 1941 to 1960 birth cohorts. The authors anticipate an increase in the proportion of new registrants, 60 years and older, with HCV will have liver cancer.

"Over the coming decade the aging of those infected with HCV will challenge the transplant community to reconsider current treatment plans given the projected increase in liver transplantation demand, particularly from patients with HCV and liver cancer," concludes Dr. Biggins. "With the aging of the population of patients with HCV, many of these patients may not be healthy enough for transplantation and the number of liver transplants in patients with HCV may decrease."

### This study was funded in part by grants from the National Center for Research Resources, the National Institute of Diabetes and Digestive and Kidney Diseases, and the Agency for Healthcare Research and Quality.

This study is published in Liver Transplantation. Media wishing to receive a PDF of the article may contact sciencenewsroom@wiley.com.

Full citation: "Projected Future Increase in Aging HCV-Infected Liver Transplant Candidates: A Potential Effect of HCC." Scott W. Biggins, Kiran M. Bambha, Norah A. Terrault, John Inadomi, Stephen Shiboski, Jennifer L. Dodge, Jane Gralla, Hugo R. Rosen and John P. Roberts. Liver Transplantation; (DOI: 10.1002/lt.23551)
Print Issue Date: December, 2012.
URL: http://doi.wiley.com/10.1002/lt.23551

Author Contact: Media wishing to speak with Dr. Biggins may contact Dan Meyers with the University of Colorado School of Medicine at dan.meyers@ucdenver.edu or at 303-724-5377

About the Journal: Liver Transplantation is published by Wiley on behalf of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. Since the first application of liver transplantation in a clinical situation was reported more than twenty years ago, there has been a great deal of growth in this field and more is anticipated. As an official publication of the AASLD and the ILTS, Liver Transplantation delivers current, peer-reviewed articles on surgical techniques, clinical investigations and drug research — the information necessary to keep abreast of this evolving specialty. For more information, please visit http://wileyonlinelibrary.com/journal/livertransplantation.

About Wiley Founded in 1807, John Wiley & Sons, Inc. has been a valued source of information and understanding for more than 200 years, helping people around the world meet their needs and fulfill their aspirations. Wiley and its acquired companies have published the works of more than 450 Nobel laureates in all categories: Literature, Economics, Physiology or Medicine, Physics, Chemistry, and Peace.

Wiley is a global provider of content and content-enabled workflow solutions in areas of scientific, technical, medical, and scholarly research; professional development; and education. Our core businesses produce scientific, technical, medical, and scholarly journals, reference works, books, database services, and advertising; professional books, subscription products, certification and training services and online applications; and education content and services including integrated online teaching and learning resources for undergraduate and graduate students and lifelong learners. Wiley's global headquarters are located in Hoboken, New Jersey, with operations in the U.S., Europe, Asia, Canada, and Australia. The Company's Web site can be accessed at http://www.wiley.com. The Company is listed on the New York Stock Exchange under the symbols JWa and JWb.

END



ELSE PRESS RELEASES FROM THIS DATE:

Don't cut corners when it comes to clean knives

2012-12-06
Poor hand hygiene is often thought to be the main cause of outbreaks of foodborne illnesses. Although it is well recognized that utensils used for food preparation can harbor bacteria, a new study by Qing Wang and her colleagues from the Center for Food Safety at the University of Georgia, USA, is the first to find that viruses can just as easily be spread by cross-contamination from utensils such as knives and graters. Their study is published in the Springer journal Food and Environmental Virology. The leading cause of foodborne illness in the US is currently Norovirus, ...

Discovery of pathway leading to depression reveals new drug targets

2012-12-06
Scientists have identified the key molecular pathway leading to depression, revealing potential new targets for drug discovery, according to research led by King's College London's Institute of Psychiatry. The study, published today in Neuropsychopharmacology, reveals for the first time that the 'Hedgehog pathway' regulates how stress hormones, usually elevated during depression, reduce the number of brain cells. Depression affects approximately 1 in 5 people in the UK at some point in their lives. The severity of symptoms can range from feelings of sadness and hopelessness ...

Kids' sleep-related breathing problems

2012-12-06
December 6, 2012 — (Bronx, NY) — Children with sleep-related breathing problems (such as snoring or apnea) frequently have concurrent behavioral sleep problems (such as waking repeatedly) — and vice versa, according to research led by a scientist at Albert Einstein College of Medicine of Yeshiva University. However, children with one type of sleep problem are not routinely evaluated and treated for the other. The findings suggest that pediatricians, respiratory specialists and sleep medicine specialists should work together whenever a sleep problem is suspected. The study ...

Fermi improves its vision for thunderstorm Gamma-ray flashes

Fermi improves its vision for thunderstorm Gamma-ray flashes
2012-12-06
Thanks to improved data analysis techniques and a new operating mode, the Gamma-ray Burst Monitor (GBM) aboard NASA's Fermi Gamma-ray Space Telescope is now 10 times better at catching the brief outbursts of high-energy light mysteriously produced above thunderstorms. The outbursts, known as terrestrial gamma-ray flashes (TGFs), last only a few thousandths of a second, but their gamma rays rank among the highest-energy light that naturally occurs on Earth. The enhanced GBM discovery rate helped scientists show most TGFs also generate a strong burst of radio waves, a finding ...

Researchers find new genetic pathway behind neurodevelopmental disorders

2012-12-06
Researchers at the Douglas Mental Health University Institute, have discovered a new genetic process that could one day provide a novel target for the treatment of neurodevelopmental disorders, such as intellectual disability and autism. The research study, which appears in the December issue of the American Journal of Human Genetics, was led by Carl Ernst, a Douglas Institute researcher, an assistant professor in McGill's Department of Psychiatry and a Canada Research Chair in Psychiatric Genetics. Ernst and his colleagues found that genetic mutations that negatively ...

Closer look at consumers' gazes

2012-12-06
Montreal, December 6, 2012 – Rows of new toys, endless racks of sweaters on clothing store shelves, long lines of books arranged in the bestsellers section at the bookstore. From mall displays to boutique exhibits, long lines of horizontally arranged products are the norm when it comes to the holiday shopping experience. But how does a product's placement on the storeroom shelf influence which one a consumer ultimately chooses? It turns out that the shopper's eye has a very central focus. "Consumers are more likely to purchase products placed in the middle of a display ...

Prenatal tests more informative using microarray technology, find GW researchers

2012-12-06
WASHINGTON – A new method for detecting abnormalities in unborn children is providing physicians with more information to analyze the results than conventional, microscopic testing, according to two George Washington University researchers. Elizabeth Thom, research professor of epidemiology and biostatistics, and Julia Zachary, senior research scientist, are co-authors of the lead article appearing in the current issue of the New England Journal of Medicine showing that microarray technology provides a more comprehensive result from genetic testing during prenatal care ...

UT MD Anderson study finds link between statins and improved survival in inflammatory breast cancer

UT MD Anderson study finds link between statins and improved survival in inflammatory breast cancer
2012-12-06
HOUSTON - Researchers from The University of Texas MD Anderson Cancer Center found statins, the commonly used drug to lower cholesterol, improved progression-free survival in patients with inflammatory breast cancer (IBC). The retrospective study was presented today in a poster discussion at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium and follows a previously reported Danish study indicating there is some evidence to suggest the anti-inflammatory properties of statins could reduce the risk of breast cancer recurrence. Still, the overall effects of statins have ...

Insect-eating bat outperforms nectar specialist as pollinator of cactus flowers

2012-12-06
SANTA CRUZ, CA--Of the two bat species known to visit the flowers of the cardon cactus in Baja California, one depends entirely on nectar and is highly specialized to feed from the flowers, which are adapted for pollination by bats. The other is an insect-eating bat best known for its ability to hear the footsteps of large insects and scorpions and capture them on the ground. In a surprising result, scientists at the University of California, Santa Cruz, have found that the insect-eating pallid bat is a more effective pollinator of the cactus flowers than the nectar-feeding ...

Tamoxifen trial should prompt breast cancer patients to reconsider treatment options

2012-12-06
MAYWOOD, Il. - A groundbreaking clinical trial involving the breast cancer drug tamoxifen should prompt certain breast cancer patients to reconsider their treatment options, according to Loyola University Medical Center breast cancer specialist Dr. Kathy Albain. The trial is called ATLAS (Adjuvant Tamoxifen Longer Against Shorter). It included women with estrogen receptor-positive breast cancer that had not spread to distant organs. Women who took tamoxifen for 10 years had a lower risk of recurrence and lower mortality rate than women who took the drug for 5 years, ...

LAST 30 PRESS RELEASES:

Impact of pollutants on pollinators, and how neural circuits adapt to temperature changes

Researchers seek to improve advanced pain management using AI for drug discovery

‘Neutron Nexus’ brings universities, ORNL together to advance science

Early release from NEJM Evidence

UMass Amherst astronomer leads science team helping to develop billion-dollar NASA satellite mission concept

Cultivating global engagement in bioengineering education to train students skills in biomedical device design and innovation

Life on Earth was more diverse than classical theory suggests 800 million years ago, a Brazilian study shows

International clean energy initiative launches global biomass resource assessment

How much do avoidable deaths impact the economy?

Federal government may be paying twice for care of veterans enrolled in Medicare Advantage plans

New therapeutic target for cardiac arrhythmias emerges

UC Irvine researchers are first to reveal role of ophthalmic acid in motor function control

Moffitt study unveils the role of gamma-delta T cells in cancer immunology

Drier winter habitat impacts songbirds’ ability to survive migration

Donors enable 445 TPDA awards to Neuroscience 2024

Gut bacteria engineered to act as tumor GPS for immunotherapies

Are auditory magic tricks possible for a blind audience?

Research points to potential new treatment for aggressive prostate cancer subtype

Studies examine growing US mental health safety net

Social risk factor domains and preventive care services in US adults

Online medication abortion direct-to-patient fulfillment before and after the Dobbs v Jackson decision

Black, Hispanic, and American Indian adolescents likelier than white adolescents to be tested for drugs, alcohol at pediatric trauma centers

Pterosaurs needed feet on the ground to become giants

Scientists uncover auditory “sixth sense” in geckos

Almost half of persons who inject drugs (PWID) with endocarditis will die within five years; women are disproportionately affected

Experimental blood test improves early detection of pancreatic cancer

Groundbreaking wastewater treatment research led by Oxford Brookes targets global challenge of toxic ‘forever chemicals’

Jefferson Health awarded $2.4 million in PCORI funding

Cilta-cel found highly effective in first real-world study

Unleashing the power of generative AI on smart collaborative innovation network platform to empower research and technology innovation

[Press-News.org] Aging hepatitis C population escalates demand for liver transplantation
Increase driven by liver cancer development in baby boomers